Clinical Pharmacology of Miami

Hialeah, Florida 33104

0 studies enrolling now · 15 studies all time

What they study most

Acute Pain, Advanced Malignancies, Chronic Kidney Disease, Chronic Kidney Disease, Stage 3 (Moderate), Chronic Kidney Disease, Stage 4 (Severe), Diabetes, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type II, Healthy Volunteers, Hemodialysis, Hepatic Impairment, Obesity

Studies at this site

A Study of LY3502970 in Participants With Type 2 Diabetes — Completed
XG005 for Pain Control in Subjects Undergoing Bunionectomy — Completed
Evaluation of Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy — Completed
Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus — Completed
A Study of TAK-881 in Healthy Adults — Completed
A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide — Completed
A Study of Mobocertinib Capsules in People With Severe Kidney Problems and People With Healthy Kidneys — Completed
A Study to Evaluate Pharmacokinetics (PK) and Safety of Oral Mobocertinib in Participants With Moderate or Severe Hepatic Impairment (HI) and Normal Hepatic Function — Completed
Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Dose of GV101 in Healthy Subjects — Completed
Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB000928 in Participants With Impaired Renal Function and Hemodialysis — Completed
The Effect o f Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Betrixiban, an Oral FXa Antagonist — Completed
Safety, Tolerability, and Pharmacokinetics of EQU-001 in Healthy Volunteers — Completed
To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Hepatic Function and Hepatic Impairment. — Completed
To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Renal Function and Renal Impairment. — Completed
Study to Assess PK, Safety and Tolerability in Patients With DM and CKD — Completed